Pharma Journalist -

Aprecia Pharmaceuticals and Cycle Pharmaceuticals announced they have signed a partnership agreement to develop and commercialize  orphan drugs using three-dimensionally printed…
Read More...

Medicure announced that, through its subsidiary, Medicure International Inc., it has acquired, from a large multinational pharmaceutical company, an exclusive license to sell and market…
Read More...

BioVectra Inc., an innovative global contract development and manufacturing organization (CDMO), announced a long-term supply agreement with Keryx Biopharmaceuticals, Inc., to…
Read More...

Pfizer Inc. announced that the United States Food and Drug Administration (FDA) has approved XELJANZ® 5 mg twice daily (BID) and XELJANZ® XR (tofacitinib) extended release 11 mg once…
Read More...

Zytoprotec announced that the United States Food and Drug Administration (FDA) has granted orphan drug designation to PD-protec, the Company's peritoneal dialysis fluid for the…
Read More...

PAREXEL International Corporation introduced the Perceptive Cloud to the life sciences industry, as part of the organization’s recent alliance with Microsoft Corp. Perceptive Cloud…
Read More...

SMi are delighted to welcome Oliver Rausch, VP Research & Development, Storm Therapeutics, onto the speaker line-up for day 1 at RNA Therapeutics 2018! Oliver has overall…
Read More...

SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, is now offering clients large molecule bioanalytical services at its laboratory in Wavre,…
Read More...

Abzena plc has entered into a Master Services Agreement with a US biotech company to provide process development and manufacturing services to progress a novel antibody-drug conjugate…
Read More...

MeiraGTx announced that the Offices of Orphan Products Development and Pediatric Therapeutics of the U.S. Food and Drug Administration (FDA) have granted rare pediatric disease…
Read More...